Tissue factor pathway inhibitor induces expression of JUNB and GADD45B mRNAs

Biochemical and Biophysical Research Communications

Volumn 299, Issue 5, 2002, Pages 847-852

  Shirotani Ikejima, Hiroko ^a   Kokame, Koichi ^a   Hamuro, Tsutomu ^b   Bu, Guojun ^c   Kato, Hisao ^a   Miyata, Toshiyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GADD45B; JUNB; Tissue factor pathway inhibitor; Very low density lipoprotein receptor

Indexed keywords

ANTITHROMBIN; LIGAND; MESSENGER RNA; SERINE PROTEINASE INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CONTROLLED STUDY; GADD45B GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; JUNB GENE; LIGAND BINDING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN BINDING;

ANTIGENS, DIFFERENTIATION; BLOTTING, NORTHERN; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN; LIPOPROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; UP-REGULATION;

EID: 0036929420     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02759-6     Document Type: Article

References (38)

1. G.J. Broze Jr., Tissue factor pathway inhibitor and the current concept of blood coagulation, Blood Coagul. Fibrinolysis 6 (Suppl. 1) (1995) S7-S13.
2. H. Kato, Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: Basic and clinical aspects, Arterioscler. Thromb. Vasc. Biol. 22 (2002) 539-548.
3. T.C. Wun, K.K. Kretzmer, T.J. Girard, J.P. Miletich, G.J. Broze Jr., Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains, J. Biol. Chem. 263 (1988) 6001-6004.
4. T.J. Girard, L.A. Warren, W.F. Novotny, K.M. Likert, S.G. Brown, J.P. Miletich, G.J. Broze Jr., Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor, Nature 338 (1989) 518-520.
5. R. Wesselschmidt, K. Likert, T. Girard, T.C. Wun, G.J. Broze Jr., Tissue factor pathway inhibitor: The carboxy-terminus is required for optimal inhibition of factor Xa, Blood 79 (1992) 2004-2010.
6. R. Wesselschmidt, K. Likert, Z. Huang, L. MacPhail, G.J. Broze Jr., Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin, Blood Coagul. Fibrinolysis 4 (1993) 661-669.
7. 243, of the third Kunitz domain is a heparin-binding site, Biochemistry 34 (1995) 5725-5735.
8. S. Mine, T. Yamazaki, T. Miyata, S. Hara, H. Kato, Structural mechanism for heparin-binding of the third Kunitz domain of human tissue factor pathway inhibitor, Biochemistry 41 (2002) 78-85.
9. Y. Jang, L.A. Guzman, A.M. Lincoff, M. Gottsauner-Wolf, F. Forudi, C.E. Hart, D.W. Courtman, M. Ezban, S.G. Ellis, E.J. Topol, Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model, Circulation 92 (1995) 3041-3050.
10. L. Oltrona, C.M. Speidel, D. Recchia, S.A. Wickline, P.R. Eisenberg, D.R. Abendschein, Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs, Circulation 96 (1997) 646-652.
11. P. Zoldhelyi, J. McNatt, H.S. Shelat, Y. Yamamoto, Z.Q. Chen, J.T. Willerson, Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor, Circulation 101 (2000) 289-295.
12. Y. Sato, Y. Asada, K. Marutsuka, K. Hatakeyama, Y. Kamikubo, A. Sumiyoshi, Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex, Thromb. Haemost. 78 (1997) 1138-1141.
13. Y. Kamikubo, Y. Nakahara, S. Takemoto, T. Hamuro, S. Miyamoto, A. Funatsu, Human recombinant tissue-factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells, FEBS Lett. 407 (1997) 116-120.
14. T. Hamuro, Y. Kamikubo, Y. Nakahara, S. Miyamoto, A. Funatsu, Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells, FEBS Lett. 421 (1998) 197-202.
15. T.A. Hembrough, J.F. Ruiz, A.E. Papathanassiu, S.J. Green, D.K. Strickland, Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor, J. Biol. Chem. 276 (2001) 12241-12248.
16. I. Warshawsky, G. Bu, A.L. Schwartz, Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein, J. Biol. Chem. 268 (1993) 22046-22054.
17. K. Kokame, K.L. Agarwala, H. Kato, T. Miyata, Herp, a new ubiquitin-like membrane protein induced by endoplasmic reticulum stress, J. Biol. Chem. 275 (2000) 32846-32853.
18. J.D. Ashcom, S.E. Tiller, K. Dickerson, J.L. Cravens, W.S. Argraves, D.K. Strickland, The human α2-macroglobulin receptor: Identification of a 420-kDa cell surface glycoprotein specific for the activated conformation of α2-macroglobulin, J. Cell Biol. 110 (1990) 1041-1048.
19. D.K. Strickland, M.Z. Kounnas, W.S. Argraves, LDL receptor-related protein: A multiligand receptor for lipoprotein and proteinase catabolism, FASEB J. 9 (1995) 890-898.
20. K.M. Argraves, F.D. Battey, C.D. MacCalman, K.R. McCrae, M. Gåfvels, K.F. Kozarsky, D.A. Chappell, J.F. Strauss III, D.K. Strickland, The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasmin-ogen activator inhibitor type I complexes, J. Biol. Chem. 270 (1995) 26550-26557.
21. S.R. Coughlin, Thrombin signalling and protease-activated receptors, Nature 407 (2000) 258-264.
22. C.T. Esmon, The endothelial cell protein C receptor, Thromb. Haemost. 83 (2000) 639-643.
23. C.T. Esmon, Introduction: Are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? Blood 95 (2000) 1113-1116.
24. F.B. Taylor Jr., D.J. Stearns-Kurosawa, S. Kurosawa, G. Ferrell, A.C. Chang, Z. Laszik, S. Kosanke, G. Peer, C.T. Esmon, The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis, Blood 95 (2000) 1680-1686.
25. D.E. Joyce, L. Gelbert, A. Ciaccia, B. DeHoff, B.W. Grinnell, Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis, J. Biol. Chem. 276 (2001) 11199-11203.
26. M. Riewald, R.J. Petrovan, A. Donner, B.M. Mueller, W. Ruf, Activation of endothelial cell protease activated receptor 1 by the protein C pathway, Science 296 (2002) 1880-1882.
27. M.S. O'Reilly, S. Pirie-Shepherd, W.S. Lane, J. Folkman, Antiangiogenic activity of the cleaved conformation of the serpin antithrombin, Science 285 (1999) 1926-1928.
28. S. Dunzendorfer, N. Kaneider, A. Rabensteiner, C. Meierhofer, C. Reinisch, J. Römisch, C.J. Wiedermann, Cell-surface heparin sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III, Blood 97 (2001) 1079-1085.
29. N.C. Kaneider, C.M. Reinisch, S. Dunzendorfer, J. Römisch, C.J. Wiederman, Syndecan-4 mediates antithrombin-induced chemo-taxis of human peripheral blood lymphocytes and monocytes, J. Cell Sci. 115 (2002) 227-236.
30. A. Kawaguchi, Y. Miyao, T. Noguchi, H. Nonogi, M. Yamagishi, K. Miyatake, Y. Kamikubo, K. Kumeda, M. Tsushima, A. Yamamoto, H. Kato, Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II, Arterioscler. Thromb. Vasc. Biol. 20 (2000) 251-258.
31. A. Kereveur, K. Enjyoji, K. Masuda, C. Yutani, H. Kato, Production of tissue factor pathway inhibitor in cardiomyocytes and its upregulation by interleukin-1, Thromb. Haemost. 86 (2001) 1314-1319.
32. M. Trommsdorff, M. Gotthardt, T. Hiesberger, J. Shelton, W. Stockinger, J. Nimpf, R.E. Hammer, J.A. Richardson, J. Herz, Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and apoE receptor 2, Cell 97 (1999) 689-701.
33. T. Hiesberger, M. Trommsdorff, B.W. Howell, A. Goffinet, M.C. Mumby, J.A. Cooper, J. Herz, Direct binding of Reelin to VLDL receptor and apoE receptor 2 induces tyrosine phosphorylation of Disabled-1 and modulates tau phosphorylation, Neuron 24 (1999) 481-489.
34. P. Angel, M. Karin, The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation, Biochim. Biophys. Acta 1072 (1991) 129-157.
35. INK4a expression, EMBO J. 19 (2000) 2969-2979.
36. A.J. Fornace Jr., I. Alamo Jr., M.C. Hollander, DNA damage-inducible transcripts in mammalian cells, Proc. Natl. Acad. Sci. USA 85 (1988) 8800-8804.
37. M. Takekawa, H. Saito, A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK, Cell 95 (1998) 521-530.
38. E. De Smaele, F. Zazzeroni, S. Papa, D.U. Nguyen, R. Jin, J. Jones, R. Cong, G. Franzoso, Induction of gadd45β by NFκB downregulates pro-apoptotic JNK signalling, Nature 414 (2001) 308-313.